Expression of Toll-like receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients with inflammatory bowel diseases: Upregulated expression of TLR2 in terminal ileum of patients with ulcerative colitis

Journal of Histochemistry and Cytochemistry

Volumn 56, Issue 3, 2008, Pages 267-274

  Frolova, Lenka ^a   Drastich, Pavel ^b   Rossmann, Pavel ^a   Klimesova, Klara ^a   Tlaskalova Hogenova, Helena ^a  

^a INSTITUTE OF MICROBIOLOGY   (Czech Republic)

^b INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

CD14; Crohn's disease; Gut; Gut mucosa; Intestinal inflammation; Mucosal immunity; Toll like receptors

Indexed keywords

CD14 ANTIGEN; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ARTICLE; CONTROLLED STUDY; ENTERITIS; FROZEN SECTION; GASTROINTESTINAL BIOPSY; HUMAN; HUMAN CELL; HUMAN TISSUE; ILEUM; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMALL INTESTINE ABSORPTION; ULCERATIVE COLITIS; UPREGULATION;

ANTIGENS, CD14; BIOPSY; CECUM; COLITIS, ULCERATIVE; CROHN DISEASE; HUMANS; ILEUM; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; RECTUM; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

BACTERIA (MICROORGANISMS);

EID: 39449127013     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.7A7303.2007     Document Type: Article

References (39)

1. Abreu MT, Arnold ET, Thomas LS, Gonsky R, Zhou Y, Hu B, Arditi M (2002) TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. J Biol Chem 227:20431-20437
2. Aderem A, Ulevitch RJ (2000) Toll-like receptors in the induction of the innate immune response. Nature 406:782-787
3. Akira S, Hemmi H (2003) Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 85:85-95
4. Autschbach F, Giese T, Gassler N, Sido B, Heuschen G, Heuschen U, Zuna I, et al. (2002) Cytokine/chemokine messenger-RNA expression profiles in ulcerative colitis and Crohn's disease. Virchows Arch 441:500-513
5. Best WR (2006) Predicting the Crohn's disease activity index from the Harvey-Bradshaw Index. Inflamm Bowel Dis 12:304-310
6. Brandtzaeg P (2001) Inflammatory bowel disease: clinics and pathology. Do inflammatory bowel disease and periodontal disease have similar immunopathogeneses? Acta Odontol Scand 59:235-243
7. Cario E, Brown D, McKee M, Lynch-Devaney K, Gerken G, Podolsky DK (2002) Commensal- associated molecular patterns induce selective Toll-like receptor-trafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium. Am J Pathol 160:165-173
8. Cario E, Podolsky D (2000) Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 68:7010-7017
9. Danese S, Sans M, Fiocchi C (2004) Inflammatory bowel disease: the role of environmental factors. Auroimmun Rev 3:394-400
10. Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, Meyer zum Buschenfelde KH (1995) Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 102:448-455
11. Duchmann R, May E, Heike M, Knolle P, Neurath M, Meyer zum Buschenfelde KH (1999) T cell specificity and cross reactivity towards enterobacteria, bacteroides, bifidobacterium, and antigens from resident intestinal flora in humans. Gut 44:812-818
12. Elson CO, Cong Y, McCracken VJ, Dimmitt RA, Lorenz RG, Weaver CT (2005) Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev 206:260-276
13. Fellermann K, Wehkamp J, Herrlinger KR, Stange EF (2003) Crohn's disease: a defensin deficiency syndrome? Eur J Gastroenterol Hepatol 15:627-634
14. Furrie E, Macfarlane S, Thomson G, Macfarlane GT; Microbiology & Gut Biology Group; Tayside Tissue & Tumour Bank (2005) Toll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria. Immunology 115:565-574
15. Fusunyan RD, Nanthakumar NN, Baldeon ME, Walker WA (2001) Evidence for an innate immune response in the immature human intestine: toll-like receptors on fetal enterocytes. Pediatr Res 49:589-593
16. Grimm MC, Pavli P, Van de Pol E, Doe WF (1995) Evidence for a CD14+ population of monocytes in inflammatory bowel disease mucosa - implications for pathogenesis. Clin Exp Immunol 100:291-297
17. Hanauer SB (2006) Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 12(suppl 1):S3-9
18. Hausmann M, Kiessling S, Mestermann S, Webb G, Spottl T, Andus T, Scholmerich J (2002) Toll-like receptors 2 and 4 are upregulated during intestinal inflammation. Gastroenterology 122:1987-2000
19. Hudcovic T, Stepankova R, Cebra J, Tlaskalova-Hogenova H (2001) The role of microflora in the development of intestinal inflammation: acute and chronic colitis induced by dextran sulfate in germ-free and conventionally reared immunocompetent and immunodeficient mice. Folia Microbiol (Praha) 46:565-572
20. Kawai T, Akira S (2006) TLR signaling. Cell Death Differ 13:816-825
21. Lange S, Delbro DS, Jennische E, Mattsby-Baltzer I (1996) The role of Lps gene in experimental ulcerative colitis in mice. APMIS 104:823-833
22. high T cells in inflammatory bowel disease. Gastroenterology 128:1868-1878
23. Medvedev AE, Lentschat A, Wahl LM, Golenbock DT, Vogel SN (2002) Dysregulation of LPS-induced Toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin-tolerant cells. J Immunol 169:5209-5216
24. Melmed G, Thomas LS, Lee N, Tesfay SY, Lukasek K, Michelsen KS, Zhou Y, et al. (2003) Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. J Immunol 170:1406-1415
25. Nomura F, Akashi S, Sakao Y, Sato S, Kawai T, Matsumoto M, Nakanishi K, et al. (2000) Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with downregulation of surface toll-like receptor 4 expression. J Immunol 164:3476-3479
26. Pugin J, Schurer-Maly CC, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS (1993) Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci USA 90:2744-2748
27. Rogler G, Andus T, Aschenbrenner E, Vogl D, Falk W, Scholmerich J, Gross V (1997) Alterations of the phenotype of colonic macrophages in inflammatory bowel disease. Eur J Gastroenterol Hepatol 9:893-899
28. Rugtveit J, Brandtzaeg P, Halstensen TS, Fausa O, Scott H (1994) Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Gut 35:669-674
29. Savage DC (1999) Mucosal microbiota. In Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee J, eds. Mucosal Immunology. New York, Academic Press, 19-30
30. Schumann RR, Rietschel ET, Loppnow H (1994) The role of CD14 and lipopolysaccharide-binding protein (LBP) in the activation of different cell types by endotoxin. Med Microbiol Immunol (Berl) 183:279-297
31. Singh B, Read S, Asseman C, Malmstrom V, Mottet C, Stephens LA, Stepankova R, et al. (2001) Control of intestinal inflammation by regulatory T cells. Immunol Rev 182:190-200
32. Smith PD, Ochsenbauer-Jambor C, Smythies LE (2005) Intestinal macrophages: unique effector cells of the innate immune system. Immunol Rev 206:149-159
33. Swidsinski A, Weber J, Loening-Baucke V, Hale LP, Lochs H (2005) Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol 43:3380-3389
34. Tlaskalova-Hogenova H, Stepankova R, Hudcovic T, Tuckova L, Cukrowska B, Lodinova-Zadnikova R, Kozakova H, et al. (2004) Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett 93:97-108
35. Tlaskalova-Hogenova H, Tuckova L, Lodinova-Zadnikova R, Stepankova R, Cukrowska B, Funda DP, Striz I, et al. (2002) Mucosal immunity: its role in defense and allergy. Int Arch Allergy Immunol 128:77-89
36. Tlaskalova-Hogenova H, Tuckova L, Stepankova R, Hudcovic T, Palova-Jelinkova L, Kozakova H, Rossmann P, et al. (2005) Involvement of innate immunity in the development of inflammatory and autoimmune diseases. Ann NY Acad Sci 1051:787-798
37. Toiyama Y, Akari T, Yoshiyama S, Hiro J, Miki C, Kusunoki M (2006) The expression patterns of Toll-like receptors in the ileal pouch mucosa of postoperative ulcerative colitis patients. Surg Today 36:287-290
38. Wang JH, Doyle M, Manning BJ, Di Wu Q, Blankson S, Redmond HP (2002) Induction of bacterial lipoprotein tolerance is associated with suppression of toll-like receptor 2 expression. J Biol Chem 277:36068-36075
39. Zarember KA, Godowski PJ (2002) Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 168:554-561